Does DESFLURANE Cause Hyperthermia malignant? 44 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Hyperthermia malignant have been filed in association with DESFLURANE (Suprane). This represents 6.9% of all adverse event reports for DESFLURANE.
44
Reports of Hyperthermia malignant with DESFLURANE
6.9%
of all DESFLURANE reports
4
Deaths
20
Hospitalizations
How Dangerous Is Hyperthermia malignant From DESFLURANE?
Of the 44 reports, 4 (9.1%) resulted in death, 20 (45.5%) required hospitalization, and 11 (25.0%) were considered life-threatening.
Is Hyperthermia malignant Listed in the Official Label?
Yes, Hyperthermia malignant is listed as a known adverse reaction in the official FDA drug label for DESFLURANE.
What Other Side Effects Does DESFLURANE Cause?
Cardiac arrest (41)
Anaphylactic shock (36)
Bradycardia (30)
Hypotension (29)
Foetal exposure during pregnancy (24)
Hyperkalaemia (18)
Bronchospasm (17)
Seizure like phenomena (17)
Vocal cord dysfunction (17)
Drug ineffective (16)
What Other Drugs Cause Hyperthermia malignant?
SUCCINYLCHOLINE (276)
SEVOFLURANE (207)
PROPOFOL (205)
FORANE (170)
ROCURONIUM (114)
FENTANYL (107)
SEVOFLURANE, USP (93)
ISOFLURANE (87)
MIDAZOLAM (62)
CISATRACURIUM (60)
Which DESFLURANE Alternatives Have Lower Hyperthermia malignant Risk?
DESFLURANE vs DESIPRAMINE
DESFLURANE vs DESLORATADINE
DESFLURANE vs DESMOPRESSIN
DESFLURANE vs DESOGESTREL
DESFLURANE vs DESOGESTREL\ETHINYL ESTRADIOL